Skip to main navigation Skip to search Skip to main content

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial

  • Jonathan A Cook
  • , Piers E M Patten
  • , Nicholas Peckham
  • , Paul Moss
  • , Neil Phillips
  • , Abhishek Abhishek
  • , Thomas Roberts
  • , Marie Hodges
  • , Georgina Talbot
  • , Vicki Barber
  • , Anne Francis
  • , Adrian M Shields
  • , Lelia Duley
  • , Robbert Hoogeboom
  • , Brian J Willett
  • , Sam Scott
  • , Nilima Parry-Jones
  • , Toby A Eyre
  • , Gareth Plested
  • , Gratian Vandici
    • Farooq Ahmad Wandroo, Claire Hutchinson, Shankara Paneesha, Duncan J Murray, Nicolas Martinez-Calle, Stephen Jenkins, Earnest Heartin, Helen M Parry*
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

76 Downloads (Pure)
Filter
Active

Search results